Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 20 (6) , 435-441
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (8KL2TR000056)
- National Center for Advancing Translational Sciences
- Medical College of Wisconsin
- Mary Kay Ash Foundation
- Susan G. Komen (CCR17483233)
- American Cancer Society (86-004-26)
This publication has 18 references indexed in Scilit:
- Radiation dose to heart base linked with poorer survival in lung cancer patientsEuropean Journal of Cancer, 2017
- Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancerRadiotherapy and Oncology, 2017
- Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2017
- Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2017
- Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative MechanismsFrontiers in Oncology, 2015
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Defining a Novel Cardiac Contouring Atlas for NSCLC Using Cadaveric AnatomyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Cardiac Complications of Thoracic IrradiationJACC, 2013
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Radiation-associated cardiovascular disease: manifestations and managementSeminars in Radiation Oncology, 2003